Literature DB >> 29609908

Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent.

Huaisheng Zhang1, Jasmine Collins1, Rogers Nyamwihura1, Shelbi Ware1, Marcel Kaiser2, Ifedayo Victor Ogungbe3.   

Abstract

A series of natural products-based phenyl sulfone derivative and their property-based analogues were investigated as potential growth inhibitors of Trypanosoma brucei. Trypanosoma brucei is a kinetoplastid protozoan parasite that causes trypanosomiasis. In this work, we found that nopol- and quinoline-based phenyl sulfone derivative were the most active and selective for T. brucei, and they were not reactive towards the active thiol of T. brucei's cysteine protease rhodesain. A thiol reactive variant of the quinoline-based phenyl sulfone was subsequently investigated and found to be a moderate inhibitor of rhodesain. The quinoline-based compound that is not reactive towards rhodesain can serve a template for phenotypic-based lead discovery while its thiol-active congener can serve as template for structure-based investigation of new antitrypanosomal agents.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cysteine protease; Natural products; Quinoline; Trypanosoma brucei

Mesh:

Substances:

Year:  2018        PMID: 29609908      PMCID: PMC5912169          DOI: 10.1016/j.bmcl.2018.03.039

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

Review 1.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

Review 2.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

3.  Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.

Authors:  Bryan T Mott; Rafaela S Ferreira; Anton Simeonov; Ajit Jadhav; Kenny Kean-Hooi Ang; William Leister; Min Shen; Julia T Silveira; Patricia S Doyle; Michelle R Arkin; James H McKerrow; James Inglese; Christopher P Austin; Craig J Thomas; Brian K Shoichet; David J Maloney
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

4.  Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.

Authors:  Roberta Ettari; Lucia Tamborini; Ilenia C Angelo; Nicola Micale; Andrea Pinto; Carlo De Micheli; Paola Conti
Journal:  J Med Chem       Date:  2013-05-07       Impact factor: 7.446

5.  Trypanosoma brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-phe-ala-CHN2.

Authors:  S Scory; C R Caffrey; Y D Stierhof; A Ruppel; D Steverding
Journal:  Exp Parasitol       Date:  1999-04       Impact factor: 2.011

6.  Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei.

Authors:  L Troeberg; R E Morty; R N Pike; J D Lonsdale-Eccles; J T Palmer; J H McKerrow; T H Coetzer
Journal:  Exp Parasitol       Date:  1999-04       Impact factor: 2.011

7.  Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.

Authors:  Marcel Kaiser; Michael A Bray; Monica Cal; Bernadette Bourdin Trunz; Els Torreele; Reto Brun
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

Review 8.  The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.

Authors:  T J Schmidt; S A Khalid; A J Romanha; T Ma Alves; M W Biavatti; R Brun; F B Da Costa; S L de Castro; V F Ferreira; M V G de Lacerda; J H G Lago; L L Leon; N P Lopes; R C das Neves Amorim; M Niehues; I V Ogungbe; A M Pohlit; M T Scotti; W N Setzer; M de N C Soeiro; M Steindel; A G Tempone
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

9.  The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei.

Authors:  Luis Carvalho; Marta Martínez-García; Ignacio Pérez-Victoria; José Ignacio Manzano; Vanessa Yardley; Francisco Gamarro; José M Pérez-Victoria
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

10.  Congenital Trypanosomiasis in Child Born in France to African Mother.

Authors:  Marie-Alix Lestrade-Carluer De Kyvon; Zoha Maakaroun-Vermesse; Philippe Lanotte; Gerardo Priotto; Pere Perez-Simarro; Anne-Marie Guennoc; Bertrand De Toffol; Luc Paris; Louis Bernard; Alain Goudeau; Jacques Chandenier; Guillaume Desoubeaux
Journal:  Emerg Infect Dis       Date:  2016-05       Impact factor: 6.883

View more
  5 in total

1.  Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities.

Authors:  Huaisheng Zhang; Jasmine Collins; Rogers Nyamwihura; Olamide Crown; Oluwatomi Ajayi; Ifedayo Victor Ogungbe
Journal:  Bioorg Med Chem Lett       Date:  2020-04-28       Impact factor: 2.823

2.  A simple and convenient synthesis of 3-salicyloylquinoline-4-carboxylic esters from chromone and isatin.

Authors:  Xuequan Wang; Zhixin Yang; Weihang Miu; Pingting Ye; Mengjiao Bai; Suyue Duan; Xianfu Shen
Journal:  RSC Adv       Date:  2019-11-12       Impact factor: 4.036

3.  In Vitro and In Vivo Evaluation of an Adamantyl-Based Phenyl Sulfonyl Acetamide against Cutaneous Leishmaniasis Models of Leishmania amazonensis.

Authors:  Camila C Santos; Huaisheng Zhang; Marcos M Batista; Gabriel M de Oliveira; Kelly C Demarque; Natália L da Silva-Gomes; Otacílio C Moreira; Ifedayo Victor Ogungbe; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

4.  Nopol-Based Quinoline Derivatives as Antiplasmodial Agents.

Authors:  Rogers J Nyamwihura; Huaisheng Zhang; Jasmine T Collins; Olamide Crown; Ifedayo Victor Ogungbe
Journal:  Molecules       Date:  2021-02-14       Impact factor: 4.411

5.  New quinoline-based triazole hybrid analogs as effective inhibitors of α-amylase and α-glucosidase: Preparation, in vitro evaluation, and molecular docking along with in silico studies.

Authors:  Yousaf Khan; Shahid Iqbal; Mazloom Shah; Aneela Maalik; Rafaqat Hussain; Shoaib Khan; Imran Khan; Rami Adel Pashameah; Eman Alzahrani; Abd-ElAziem Farouk; Mohammed Issa Alahmdi; Hisham S M Abd-Rabboh
Journal:  Front Chem       Date:  2022-09-15       Impact factor: 5.545

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.